Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

被引:0
|
作者
Laura Broutier
Gianmarco Mastrogiovanni
Monique MA Verstegen
Hayley E Francies
Lena Morrill Gavarró
Charles R Bradshaw
George E Allen
Robert Arnes-Benito
Olga Sidorova
Marcia P Gaspersz
Nikitas Georgakopoulos
Bon-Kyoung Koo
Sabine Dietmann
Susan E Davies
Raaj K Praseedom
Ruby Lieshout
Jan N M IJzermans
Stephen J Wigmore
Kourosh Saeb-Parsy
Mathew J Garnett
Luc JW van der Laan
Meritxell Huch
机构
[1] The Wellcome Trust/CRUK Gurdon Institute,Department of Surgery
[2] University of Cambridge,Department of Surgery
[3] Wellcome Trust—Medical Research Council Stem Cell Institute,Department of Histopathology
[4] University of Cambridge,Department of Hepato Pancreato Biliary Surgery
[5] Erasmus MC–University Medical Center,Department of Clinical Surgery
[6] Wellcome Trust Sanger Institute,Department of Physiology
[7] Wellcome Trust Genome Campus,undefined
[8] University of Cambridge and NIHR Cambridge Biomedical Research Centre,undefined
[9] Cambridge University Hospitals NHS Foundation Trust,undefined
[10] Cambridge University Hospitals NHS Foundation Trust,undefined
[11] Royal Infirmary of Edinburgh,undefined
[12] Development and Neuroscience,undefined
[13] University of Cambridge,undefined
来源
Nature Medicine | 2017年 / 23卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Tumor organoids derived from the most common subtypes of primary liver cancer recapitulate the histologic and molecular features of the tissues of origin, even after long-term culture. These in vitro models, as well as those for colorectal cancer reported in Crespo et al. in a previous issue, are amenable for drug screening and allow the identification of therapeutic approaches with potential for cancer treatment.
引用
收藏
页码:1424 / 1435
页数:11
相关论文
共 50 条
  • [41] Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening
    Smith, Alec S. T.
    Macadangdang, Jesse
    Leung, Winnie
    Laflamme, Michael A.
    Kim, Deok-Ho
    [J]. BIOTECHNOLOGY ADVANCES, 2017, 35 (01) : 77 - 94
  • [42] Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening
    Cottier, Karissa E.
    Bhalerao, Devika
    Lewis, Candice
    Gaffney, Jeannemarie
    Heyward, Scott A.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening
    Karissa E. Cottier
    Devika Bhalerao
    Candice Lewis
    Jeannemarie Gaffney
    Scott A. Heyward
    [J]. Scientific Reports, 13
  • [44] Cancer modeling meets human organoid technology
    Tuveson, David
    Clevers, Hans
    [J]. SCIENCE, 2019, 364 (6444) : 952 - 955
  • [45] Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations
    Jabs, Julia
    Zickgraf, Franziska M.
    Park, Jeongbin
    Wagner, Steve
    Jiang, Xiaoqi
    Jechow, Katharina
    Kleinheinz, Kortine
    Toprak, Umut H.
    Schneider, Marc A.
    Meister, Michael
    Spaich, Saskia
    Suetterlin, Marc
    Schlesner, Matthias
    Trumpp, Andreas
    Sprick, Martin
    Eils, Roland
    Conrad, Christian
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2017, 13 (11)
  • [46] Does DMSO elicit toxicity in cryopreservation of liver cell derived organoid cultures?
    Erro, E.
    Awan, M.
    Forster-Brown, E.
    Watt, A.
    Chalmers, S.
    Fuller, B.
    Selden, C.
    [J]. CRYOLETTERS, 2020, 41 (03) : 183 - 184
  • [47] DEVELOPMENT OF PATIENT-DERIVED KIDNEY CANCER ORGANOID; APPLICATION TO DRUG SCREENING MODELS AND ITS CHALLENGES
    Kazama, Akira
    Bilim, Vladimir
    Tomita, Yoshihiko
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E704 - E705
  • [48] Application of triple negative breast cancer patient-derived organoid and xenograft model for drug screening
    Ryu, Seungyeon
    Kim, Hoe Suk
    Kim, Jung Eun
    Yoon, So-Hyun
    Lee, Sangeun
    Baek, Moonjou
    Lee, Han-Byoel
    Lee, Dong Woo
    Ku, Bosung
    Han, Wonshik
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [49] Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer
    Zhao, Yi
    Li, Shangru
    Zhu, Lefan
    Huang, Mingle
    Xie, Yubin
    Song, Xinming
    Chen, Zhihui
    Lau, Harry Cheuk-Hay
    Sung, Joseph Jao-Yiu
    Xu, Lixia
    Yu, Jun
    Li, Xiaoxing
    [J]. CELL REPORTS MEDICINE, 2024, 5 (07)
  • [50] Re: Organoid Cultures Derived from Patients with Advanced Prostate Cancer
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2015, 193 (04): : 1442 - +